Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Sánchez-Céspedes J[au]:

Inhibition of adenovirus infection by mifepristone. Marrugal-Lorenzo JA et al. Antiviral Res. (2018)

Perspectives for clinical use of engineered human host defense antimicrobial peptides. Pachón-Ibáñez ME et al. FEMS Microbiol Rev. (2017)

Multiple Multicomponent Reactions: Unexplored Substrates, Selective Processes, and Versatile Chemotypes in Biomedicine. Ghashghaei O et al. Chemistry. (2018)

Search results

Items: 34

1.

Structure-Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection.

Xu J, Berastegui-Cabrera J, Chen H, Pachón J, Zhou J, Sánchez-Céspedes J.

J Med Chem. 2020 Mar 26;63(6):3142-3160. doi: 10.1021/acs.jmedchem.9b01950. Epub 2020 Feb 28.

PMID:
32045239
2.

T-cells immune response controls the high incidence of adenovirus infection in adult allogenic hematopoietic transplantation recipients.

Sánchez-Céspedes J, Marrugal-Lorenzo JA, Martín-Gandul C, Rodríguez-Torres N, Montero-Mateos E, Serna-Gallego A, Escamilla-Gómez V, Merino L, Espigado I, Pachón J, Pérez-Simón JA, Aguilar-Guisado M.

Haematologica. 2020 Jan 23. pii: haematol.2019.240101. doi: 10.3324/haematol.2019.240101. [Epub ahead of print] No abstract available.

3.

Optimization of piperazine-derived ureas privileged structures for effective antiadenovirus agents.

Mazzotta S, Marrugal-Lorenzo JA, Vega-Holm M, Serna-Gallego A, Álvarez-Vidal J, Berastegui-Cabrera J, Pérez Del Palacio J, Díaz C, Aiello F, Pachón J, Iglesias-Guerra F, Vega-Pérez JM, Sánchez-Céspedes J.

Eur J Med Chem. 2020 Jan 1;185:111840. doi: 10.1016/j.ejmech.2019.111840. Epub 2019 Nov 3.

PMID:
31711794
4.

Discovery of niclosamide and its O-alkylamino-tethered derivatives as potent antibacterial agents against carbapenemase-producing and/or colistin resistant Enterobacteriaceae isolates.

Xu J, Pachón-Ibáñez ME, Cebrero-Cangueiro T, Chen H, Sánchez-Céspedes J, Zhou J.

Bioorg Med Chem Lett. 2019 Jun 1;29(11):1399-1402. doi: 10.1016/j.bmcl.2019.03.032. Epub 2019 Mar 23.

PMID:
30954430
5.

Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections.

Marrugal-Lorenzo JA, Serna-Gallego A, Berastegui-Cabrera J, Pachón J, Sánchez-Céspedes J.

Sci Rep. 2019 Jan 9;9(1):17. doi: 10.1038/s41598-018-37290-3.

6.

Impact of pretransplant CMV-specific T-cell immune response in the control of CMV infection after solid organ transplantation: a prospective cohort study.

Molina-Ortega A, Martín-Gandul C, Mena-Romo JD, Rodríguez-Hernández MJ, Suñer M, Bernal C, Sánchez M, Sánchez-Céspedes J, Pérez Romero P, Cordero E.

Clin Microbiol Infect. 2019 Jun;25(6):753-758. doi: 10.1016/j.cmi.2018.09.019. Epub 2018 Oct 5.

PMID:
30292792
7.

Inhibition of adenovirus infection by mifepristone.

Marrugal-Lorenzo JA, Serna-Gallego A, González-González L, Buñuales M, Poutou J, Pachón J, Gonzalez-Aparicio M, Hernandez-Alcoceba R, Sánchez-Céspedes J.

Antiviral Res. 2018 Nov;159:77-83. doi: 10.1016/j.antiviral.2018.09.011. Epub 2018 Sep 27.

PMID:
30268911
8.

Multiple Multicomponent Reactions: Unexplored Substrates, Selective Processes, and Versatile Chemotypes in Biomedicine.

Ghashghaei O, Caputo S, Sintes M, Revés M, Kielland N, Estarellas C, Luque FJ, Aviñó A, Eritja R, Serna-Gallego A, Marrugal-Lorenzo JA, Pachón J, Sánchez-Céspedes J, Treadwell R, de Moliner F, Vendrell M, Lavilla R.

Chemistry. 2018 Sep 25;24(54):14513-14521. doi: 10.1002/chem.201802877. Epub 2018 Aug 28.

PMID:
29974986
9.

Perspectives for clinical use of engineered human host defense antimicrobial peptides.

Pachón-Ibáñez ME, Smani Y, Pachón J, Sánchez-Céspedes J.

FEMS Microbiol Rev. 2017 May 1;41(3):323-342. doi: 10.1093/femsre/fux012. Review.

10.

New 4-Acyl-1-phenylaminocarbonyl-2-phenylpiperazine Derivatives as Potential Inhibitors of Adenovirus Infection. Synthesis, Biological Evaluation, and Structure-activity Relationships.

Sánchez-Céspedes J, Martínez-Aguado P, Vega-Holm M, Serna-Gallego A, Candela JI, Marrugal-Lorenzo JA, Pachón J, Iglesias-Guerra F, Vega-Pérez JM.

J Med Chem. 2016 Jun 9;59(11):5432-48. doi: 10.1021/acs.jmedchem.6b00300. Epub 2016 May 31.

PMID:
27195951
11.

Antiadenovirus drug discovery: potential targets and evaluation methodologies.

Martínez-Aguado P, Serna-Gallego A, Marrugal-Lorenzo JA, Gómez-Marín I, Sánchez-Céspedes J.

Drug Discov Today. 2015 Oct;20(10):1235-42. doi: 10.1016/j.drudis.2015.07.007. Epub 2015 Jul 23. Review.

PMID:
26210958
12.

Effects of a Mutation in the gyrA Gene on the Virulence of Uropathogenic Escherichia coli.

Sánchez-Céspedes J, Sáez-López E, Frimodt-Møller N, Vila J, Soto SM.

Antimicrob Agents Chemother. 2015 Aug;59(8):4662-8. doi: 10.1128/AAC.00665-15. Epub 2015 May 26.

13.

Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative.

Sanchez-Cespedes J, Moyer CL, Whitby LR, Boger DL, Nemerow GR.

Antiviral Res. 2014 Aug;108:65-73. doi: 10.1016/j.antiviral.2014.05.010. Epub 2014 Jun 4.

14.

Meningoencephalitis due to adenovirus in a healthy infant mimicking severe bacterial sepsis.

Reyes-Andrade J, Sánchez-Céspedes J, Olbrich P, Falcon L, Sanchez-Ganfornina I, Tebruegge M, Pérez-Romero P, Neth O.

Pediatr Infect Dis J. 2014 Apr;33(4):416-9. doi: 10.1097/INF.0000000000000128.

PMID:
24632664
15.

Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin.

López-Rojas R, Sánchez-Céspedes J, Docobo-Pérez F, Domínguez-Herrera J, Vila J, Pachón J.

Int J Antimicrob Agents. 2011 Oct;38(4):355-9. doi: 10.1016/j.ijantimicag.2011.06.006. Epub 2011 Aug 6.

PMID:
21820876
16.

Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates.

Lunn AD, Fàbrega A, Sánchez-Céspedes J, Vila J.

Int Microbiol. 2010 Mar;13(1):15-20.

17.

Quorum-sensing regulator sdiA and marA overexpression is involved in in vitro-selected multidrug resistance of Escherichia coli.

Tavío MM, Aquili VD, Poveda JB, Antunes NT, Sánchez-Céspedes J, Vila J.

J Antimicrob Chemother. 2010 Jun;65(6):1178-86. doi: 10.1093/jac/dkq112. Epub 2010 Apr 14.

PMID:
20395215
18.

In vitro activity of ceftobiprole against Acinetobacter baumannii clinical isolates.

Marti S, Sánchez-Céspedes J, Espinal P, Vila J.

Int J Antimicrob Agents. 2009 Sep;34(3):265-7. doi: 10.1016/j.ijantimicag.2009.03.015. Epub 2009 May 5.

PMID:
19406625
19.

Characterization of the enzyme aac(3)-Id in a clinical isolate of Salmonella enterica serovar Haifa causing traveler's diarrhea.

Cabrera R, Ruiz J, Sánchez-Céspedes J, Goñi P, Gómez-Lus R, Jiménez de Anta MT, Gascón J, Vila J.

Enferm Infecc Microbiol Clin. 2009 Oct;27(8):453-6. doi: 10.1016/j.eimc.2008.11.016. Epub 2009 Apr 29.

PMID:
19403206
20.

Synthesis of a library of psi-stylostatins with potential antibacterial activity.

López C, Cruz M, Sánchez-Cespedes J, Diez A.

Adv Exp Med Biol. 2009;611:97-8. No abstract available.

PMID:
19400110
21.

Two chromosomally located qnrB variants, qnrB6 and the new qnrB16, in Citrobacter spp. isolates causing bacteraemia.

Sanchez-Cespedes J, Marti S, Soto SM, Alba V, Melción C, Almela M, Marco F, Vila J.

Clin Microbiol Infect. 2009 Dec;15(12):1132-8. doi: 10.1111/j.1469-0691.2009.02744.x. Epub 2009 Apr 23.

22.

Development of imipenem resistance in an Aeromonas veronii biovar sobria clinical isolate recovered from a patient with cholangitis.

Sánchez-Céspedes J, Figueras MJ, Aspiroz C, Aldea MJ, Toledo M, Alperí A, Marco F, Vila J.

J Med Microbiol. 2009 Apr;58(Pt 4):451-5. doi: 10.1099/jmm.0.47804-0.

PMID:
19273640
23.

In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.

Marti S, Sánchez-Céspedes J, Alba V, Vila J.

Int J Antimicrob Agents. 2009 Feb;33(2):181-2. doi: 10.1016/j.ijantimicag.2008.08.015. Epub 2008 Nov 1.

PMID:
18977642
24.

Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.

Madurga S, Sánchez-Céspedes J, Belda I, Vila J, Giralt E.

Chembiochem. 2008 Sep 1;9(13):2081-6. doi: 10.1002/cbic.200800041.

PMID:
18677735
25.

Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate.

Sánchez-Céspedes J, Blasco MD, Marti S, Alba V, Alcalde E, Esteve C, Vila J.

Antimicrob Agents Chemother. 2008 Aug;52(8):2990-1. doi: 10.1128/AAC.00287-08. Epub 2008 May 27. No abstract available.

26.

Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.

Marti S, Sánchez-Céspedes J, Blasco MD, Ruiz M, Espinal P, Alba V, Fernández-Cuenca F, Pascual A, Vila J.

Antimicrob Agents Chemother. 2008 Aug;52(8):2955-8. doi: 10.1128/AAC.00072-08. Epub 2008 May 27.

27.

Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ct13TU clinical isolate.

Marti S, Sánchez-Céspedes J, Blasco MD, Espinal P, Ruiz M, Alba V, Vila J.

Diagn Microbiol Infect Dis. 2008 Aug;61(4):468-70. doi: 10.1016/j.diagmicrobio.2008.03.014. Epub 2008 May 15.

PMID:
18485655
28.

Quinolone resistance in the food chain.

Fàbrega A, Sánchez-Céspedes J, Soto S, Vila J.

Int J Antimicrob Agents. 2008 Apr;31(4):307-15. doi: 10.1016/j.ijantimicag.2007.12.010. Epub 2008 Mar 4. Review.

PMID:
18308515
29.

Partial characterisation of the acrAB locus in two Citrobacter freundii clinical isolates.

Sánchez-Céspedes J, Vila J.

Int J Antimicrob Agents. 2007 Sep;30(3):259-63. Epub 2007 Jul 13.

PMID:
17631985
30.

Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.

Vila J, Martí S, Sánchez-Céspedes J.

J Antimicrob Chemother. 2007 Jun;59(6):1210-5. Epub 2007 Feb 26. Review.

PMID:
17324960
31.

Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria.

Vila J, Sánchez-Céspedes J, Sierra JM, Piqueras M, Nicolás E, Freixas J, Giralt E.

Int J Antimicrob Agents. 2006 Jul;28(1):19-24. Epub 2006 Jun 14.

PMID:
16781123
32.

Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii.

Martí S, Sánchez-Céspedes J, Oliveira E, Bellido D, Giralt E, Vila J.

Proteomics. 2006 Apr;6 Suppl 1:S82-7. Review.

PMID:
16544276
33.

Detection of dihydrofolate reductase genes by PCR and RFLP.

Navia MM, Ruiz J, Sanchez-Cespedes J, Vila J.

Diagn Microbiol Infect Dis. 2003 Aug;46(4):295-8.

PMID:
12944023
34.

Clonal dissemination of Yersinia enterocolitica strains with various susceptibilities to nalidixic acid.

Sánchez-Céspedes J, Navia MM, Martínez R, Orden B, Millán R, Ruiz J, Vila J.

J Clin Microbiol. 2003 Apr;41(4):1769-71.

Supplemental Content

Loading ...
Support Center